"10.1371_journal.pone.0076225","plos one","2013-10-03T00:00:00Z","Rebekah W Moehring; Richard Sloane; Luke F Chen; Emily C Smathers; Kenneth E Schmader; Vance G Fowler; David J Weber; Daniel J Sexton; Deverick J Anderson","Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America; Division of Geriatrics, Duke University Medical Center, Durham, North Carolina, United States of America; Geriatric Research Education and Clinical Center, Durham Veterans Affairs Medical Center, Durham, North Carolina, United States of America; Department of Medicine, Division of Infectious Diseases, Durham Veterans Affairs Medical Center, Durham, North Carolina, United States of America; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America","Conceived and designed the experiments: RWM DJA DJS KES. Performed the experiments: RWM RS ECS DJA. Analyzed the data: RWM RS DJA. Contributed reagents/materials/analysis tools: RWM RS DJA. Wrote the manuscript: RWM DJA DJS DJW. Provided critical review and edits of the manuscript: LFC VGF DJW KES.","The authors have read the journals policy and have the following conflicts: Rebekah W. Moehring – RWM has no direct conflicts. RWM has received royalties from UpToDate, Inc.
Richard Sloane - None. Luke F. Chen – LFC has no direct conflicts. LFC received grant support from Merck and Optimer Pharmaceuticals, and is on the speakers bureau for Cubist and Optimer.
Emily C. Smathers - None. Kenneth E. Schmader – KES has no direct conflicts, he has received grant support from Merck. Vance G. Fowler Jr. - VGF has no direct conflicts. He was chair of Merck V710 Scientific Advisory Committee, has received grant support from Merck, Cerexa, Pfizer, Novartis, Advanced Liquid Logics, MedImmune, and the National Institutes of Health, has been a paid consultant for Merck, Astellas, Affinium, Theravance, Cubist, Cerexa, Durata, Pfizer, NovaDigm, Novartis, Medicines Company, Biosynexus, MedImmune, Galderma, and Inimex, and has received honoraria from Merck, Astellas, Cubist, Pfizer, Theravance, and Novartis. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","10","Rebekah W Moehring","RWM",9,TRUE,4,4,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
